325 related articles for article (PubMed ID: 29650125)
1. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.
Torrado J; Buckley L; Durán A; Trujillo P; Toldo S; Valle Raleigh J; Abbate A; Biondi-Zoccai G; Guzmán LA
J Am Coll Cardiol; 2018 Apr; 71(15):1676-1695. PubMed ID: 29650125
[TBL] [Abstract][Full Text] [Related]
2. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
3. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
[TBL] [Abstract][Full Text] [Related]
4. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.
Byrne RA; Joner M; Kastrati A
Eur Heart J; 2015 Dec; 36(47):3320-31. PubMed ID: 26417060
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: issues of late stent thrombosis.
Lemesle G; Maluenda G; Collins SD; Waksman R
Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of the drug-eluting stent: a double-edged sword?
Chen JP
South Med J; 2008 Feb; 101(2):174-8. PubMed ID: 18364620
[TBL] [Abstract][Full Text] [Related]
7. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
9. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
[TBL] [Abstract][Full Text] [Related]
10. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
11. Stent restenosis and thrombosis: etiology, treatment, and outcomes.
van Buuren F; Dahm JB; Horskotte D
Minerva Med; 2012 Dec; 103(6):503-11. PubMed ID: 23229369
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stent thrombosis.
Steinberg DH; Satler LF
Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
[TBL] [Abstract][Full Text] [Related]
13. Safety of drug eluting stents: current concerns and controversies.
Raja SG; Berg GA
Curr Drug Saf; 2007 Sep; 2(3):212-9. PubMed ID: 18690970
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stent safety.
Slottow TL; Waksman R
Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
[TBL] [Abstract][Full Text] [Related]
15. In-stent restenosis and thrombosis 41 months after drug-eluting stent implantation.
Jamshidi P; Toggweiler S; Erne P
Int J Cardiol; 2008 Nov; 130(3):e111-3. PubMed ID: 17727982
[TBL] [Abstract][Full Text] [Related]
16. [The bioresorbable coronary stent: a revolution].
Koegler F; De Benedetti E
Rev Med Suisse; 2013 Apr; 9(381):775-8. PubMed ID: 23659156
[TBL] [Abstract][Full Text] [Related]
17. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
Kumbhani DJ; Bavry AA; Bhatt DL
Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
[TBL] [Abstract][Full Text] [Related]
18. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents to prevent stent thrombosis and restenosis.
Im E; Hong MK
Expert Rev Cardiovasc Ther; 2016; 14(1):87-104. PubMed ID: 26567863
[TBL] [Abstract][Full Text] [Related]
20. In-stent restenosis.
Kim MS; Dean LS
Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
